A Rare Case of Cyclophosphamide-Induced Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-GBM Vasculitis, and Review of Current Literature.
Taha NisarAbdul R AlchakiErin FeinsteinPublished in: Case reports in neurological medicine (2019)
Posterior reversible encephalopathy syndrome (PRES) is a clinical syndrome of headache, altered mental status, and seizures with reversible mainly posterior leukoencephalopathy on neuroimaging. Precipitating factors for PRES are multifactorial and include autoregulatory failure due to changes in blood pressure, metabolic derangements, and cytotoxic medications. We report the second case of cyclophosphamide-induced PRES in a patient with anti-glomerular basement membrane (Anti-GBM) positive vasculitis. In the acute setting, PRES can be challenging to distinguish from cerebral venous sinus thrombosis or cerebral vasculitis based on clinical presentation. Neuroimaging with magnetic resonance imaging (MRI) of the brain along with a vessel imaging, can help reach the diagnosis.
Keyphrases
- case report
- magnetic resonance imaging
- high glucose
- rare case
- blood pressure
- drug induced
- low dose
- diabetic rats
- systematic review
- subarachnoid hemorrhage
- early onset
- high dose
- mental health
- contrast enhanced
- endothelial cells
- high resolution
- liver failure
- computed tomography
- type diabetes
- white matter
- metabolic syndrome
- mass spectrometry
- hepatitis b virus
- heart rate
- adipose tissue
- brain injury
- acute respiratory distress syndrome
- photodynamic therapy
- insulin resistance
- mechanical ventilation